New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Cristiano Ronaldo Rape Allegation Case: Why Did Portuguese Superstar Stop Visiting US After 2014?
SS Rajamouli Faces FIR For 'Hurting' Religious Sentiments Over Controversial Lord Hanuman Remark At Varanasi Event In Hyderabad
'Strongest AI Model In The World': Gemini 3 Released For All Users, Google Antigravity Tool Announced As Well
Sensex, Nifty Open Flat, Mixed Global Cues & Lack Of Major Domestic Triggers Keep Investor Sentiment Muted
